Form 4 for ERNA Ernexa Therapeutics Inc.
Accepted 2022-06-29 00:00:00 ET · period of report 2022-06-28 · accession 0001140361-22-024524 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-29 | 2022-06-28 | ERNA | DAmour Kevin | CSO | M - OptEx | — | +17.6K | 17.6K | New | — |
| D | 2022-06-29 | 2022-06-28 | ERNA | DAmour Kevin | CSO | F - Tax | $0.55 | -6,077 | 11.5K | -35% | -$3,342 |
| D | 2022-06-29 | 2022-06-28 | ERNA | DAmour Kevin | CSO | M - OptEx | $0.00 | -17.6K | 52.7K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-28 | M | A | 17,573 | — | 17,573 | D | — | — | (F1) Each restricted stock unit converts into one share of common stock. |
| 2 | Common | Common Stock | 2022-06-28 | F | D | 6,077 | $0.55 | 11,496 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-06-28 | M | D | 17,573 | $0.00 | 52,717 | D | — · — to — | 17,573 Common Stock | (F1) Each restricted stock unit converts into one share of common stock. (F2) On June 28, 2021, the reporting person was granted 70,290 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date. |